EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)
Clinical trial NCT07646171 · RECRUITING
Trial details
- NCT number
- NCT07646171
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2026-12-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.